ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Well-reduced bisphosphonate-associated atypical femur fractures have low rates of nonunion and delayed union.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBisphosphonate-associated atypical femur fractures have been reported to have high rates of delayed union and nonunion, as well as high rates of contralateral fracture. There have been limited studies looking at specific factors associated with delayed union or nonunion of atypical fractures. Many studies are limited by small numbers of patients. To date, no studies have examined the effect of reduction technique (closed versus open versus percutaneous) and reduction quality on healing.
methodsThis was a multicentered retrospective review of patients greater than 50 years of age with atypical femur fractures treated surgically at level 1 orthopedic trauma center. Patients who were lost to follow-up prior to radiographic union or who were lost to follow-up prior to 6 month follow-up and who had not yet achieved radiographic union were excluded. The primary outcome was union. Secondary outcomes included time to radiographic healing and reoperation.
resultsA total of 148 patients with atypical femoral shaft fractures were identified; 75 patients met inclusion criteria. All were female, with an average age of 75 (standard deviation 8.8). Fifty underwent a closed reduction, 15 underwent open reduction, and 10 had a percutaneous reduction. Reduction quality was excellent in 97% of patients. All patients were treated with an intramedullary implant. Two patients (3%) went on to nonunion, which was diagnosed at an average of nine months postoperatively. Three patients (4%) had delayed union. The median time to union was 3.1 months (IQR 2.9-3.6). In univariate analysis, subtrochanteric fracture location, poor reduction quality, open fracture, and open reduction were each independently associated with increased risk of nonunion or delayed union. The rate of contralateral fracture was only 5% at a median follow-up of 4 years. DISCUSSION/
conclusionIn this cohort of patients with a high rate of well-reduced bisphosphonate-associated femoral shaft fractures, the rate of nonunion and delayed union as well as the median time to radiographic union is significantly lower than has been previously reported. Varus and flexion malreduction, fracture plane gap, open fracture, performing an open reduction, and subtrochanteric fracture location were each independently associated with increased risk of nonunion and delayed union. Finally, there was a low rate (5%) of contralateral fracture.
Indexed as
Identifiers
40474014What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.